Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama
Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama
Recruiting · NCT05654467 · Registry updated 2026-05-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 2 | 2026-05-11 | NCT05654467 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bill and Melinda Gates Foundation | 67 |
| Centers for Disease Control and Prevention | 84 |
| PATH | 16 |
| PT Bio Farma | 8 |
| Technical Resources International, Inc. | 4 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cevaxin - 24 de Diciembre | Panama City | Panama | 2 |
| Cevaxin - Chorrera | Panama City | Panama | 2 |
| Cevaxin-- Avenida Mexico | Panama City | Panama | 1 |